retatrutide clinical trials weight loss Treatment Explained Perceived benefits of treatment for

To view a copy of this licence, visit About this article Cite this article Pan, HC., Chen, JY., Chen, HY

Additional information Managed by Massimo Federici

3.7 Cancer risk by individual GLP-1 RA compound When stratified by individual GLP-1 RAs, liraglutide and semaglutide were associated with reduced risk of gastrointestinal cancers (HR 0.77 and 0.79, respectively), while dulaglutide showed a neutral association (HR 0.91, 95% CI: 0.721.14)

Maybe it was a Facebook video with a countdown clock ticking down, maybe it was an Instagram testimonial from someone who says they're sixteen pounds lighter, maybe it was a friend's recommendation